Pitti Group Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
VCM
VPM
Pitti Group Wealth Management's ABBV Position: Q1 2026 in Review
Pitti Group Wealth Management increased its AbbVie (ABBV) stake by 0.47% in Q1 2026, buying an estimated $1.11K and bringing the position to 1,076 shares worth $234K. The position accounts for 0.19% of the portfolio, ranked #71.
Pitti Group Wealth Management first reported a position in ABBV in Q1 2025 and has held it in 4 quarters since. The position peaked at $245K in Q4 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Pitti Group Wealth Management held 1,076 shares of AbbVie worth $234K as of Q1 2026.
- Pitti Group Wealth Management bought 5 AbbVie shares in Q1 2026, an estimated $1.11K.
- AbbVie made up 0.19% of Pitti Group Wealth Management's portfolio in Q1 2026, its #71 holding.
- Pitti Group Wealth Management first reported a position in AbbVie in Q1 2025 and has held it in 4 quarters since.
- Pitti Group Wealth Management's AbbVie position peaked at $245K in Q4 2025.
- 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Pitti Group Wealth Management's 13F filing for Q1 2026, filed 15 May 2026.